Catalyst Wire Dossier Catalyst Wire Dossier

Copaxone-Teva

glatiramer acetate · Teva
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Copaxone-Teva, covering 2021-09-16 to 2021-09-16. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of BCD-063 and Copaxone-Teva in Patients With Relapsing-Remitting Multiple Sclerosis [Phase 3]

See pricing